Literature DB >> 17662899

Therapeutical approaches in melasma.

Francesca Prignano1, Jean-Paul Ortonne, Gionata Buggiani, Torello Lotti.   

Abstract

Melasma (cloasma) is a typical hypermelanosis and a common dermatologic skin disease that involves sun-exposed areas of the skin. It mostly affects women of reproductive age. Solar and ultraviolet exposure are the most crucial etiologic factors. Pregnancy, certain endocrine disorders and hormonal treatments, cosmetics, phototoxic drugs, and antiseizure medications are well-known inducing and exacerbating factors. A classification of melasma is based on Wood's light examination, classifying it in four major clinical types and patterns: epidermal, dermal, mixed, and indeterminate. Different treatment options are currently available for melasma. The choice of proper treatment should take into account the type of melasma to be treated, the skin complexion of the patient, possible previous treatments, the expectations and compliance of the patient, and the season in which the treatment is started.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662899     DOI: 10.1016/j.det.2007.04.006

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  14 in total

Review 1.  [Fractional photothermolysis: a new option for treating melasma?].

Authors:  S Karsai; C Raulin
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

2.  Biodegradable Kojic Acid-Based Polymers: Controlled Delivery of Bioactives for Melanogenesis Inhibition.

Authors:  Jonathan J Faig; Alysha Moretti; Laurie B Joseph; Yingyue Zhang; Mary Joy Nova; Kervin Smith; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2017-01-26       Impact factor: 6.988

3.  Dermatological Conditions in SKIN OF COLOR-Melasma: Topical and Systemic Management.

Authors:  Archana M Sangha
Journal:  J Clin Aesthet Dermatol       Date:  2022-03

Review 4.  Topical Treatments for Melasma and Their Mechanism of Action.

Authors:  Valeria González-Molina; Alicia Martí-Pineda; Noelani González
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

5.  Methimazole in the Treatment of Melasma: A Clinical and Dermascopic Study.

Authors:  Azza Farag; Mostafa Hammam; Nada Alnaidany; Eman Badr; Mustafa Elshaib; Aliaa El-Swah; Wafaa Shehata
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

6.  Adverse cutaneous reactions to skin care products on the face vary with age, but not with sex.

Authors:  Li-Ning Huang; Yi-Ping Zhong; Dan Liu; Xiao-Hua Wang; Can-Yi Gong; Si Wen; Peter M Elias; Bin Yang; Mao-Qiang Man
Journal:  Contact Dermatitis       Date:  2018-09-12       Impact factor: 6.600

7.  Melasma: a clinico-epidemiological study of 312 cases.

Authors:  Arun Achar; Sanjay K Rathi
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

8.  Topical tranexamic acid as a promising treatment for melasma.

Authors:  Bahareh Ebrahimi; Farahnaz Fatemi Naeini
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

9.  Topical treatment of melasma.

Authors:  Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review.

Authors:  Lauren L Levy; Jason J Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.